![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 16-Feb-2012[ | E-mail |
Share ] Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
UMass Medical School study offers evidence that the 3D organization of chromosomes plays a part in cancer genomics
WORCESTER, Mass. -- It is well understood that chromosomal translocation a process whereby pieces of two chromosomes break off and exchange places is a hallmark of many cancers including leukemia, thyroid cancer and lymphoma and play an important part in how healthy cells become cancerous. The role spatial proximity plays in why certain chromosomal translocations happen repeatedly, however, has been a long-standing area of debate among scientists.
A new study published online in the journal Cell by lead authors Job Dekker, PhD, co-director of the Program in Systems Biology at the University of Massachusetts Medical School (UMMS) and Frederick Alt, PhD, director of the Program in Cellular and Molecular Medicine at Children's Hospital Boston, offers the first conclusive evidence that the three dimensional structure of the chromosome strongly influences patterns of chromosome rearrangements and translocations. This finding sheds light on fundamental processes related to cancer and our understanding of cancer genomics.
"Understanding how chromosome translocations happen is important if we want to understand the evolution of cancer genomes," said Rachel Patton McCord, PhD, a postdoctoral fellow at UMMS and co-first author of the study. "If certain individuals have changes in their chromosome structure it might indicate an increased risk for translocations that give rise to cancer. And, after precancerous changes have taken place in the genome of the cell, corresponding rearrangements in the 3D genome may dictate which translocations happen as cancer progresses."
In order to measure how all the sequences in the genome are organized relative to one another, McCord used a molecular technology developed in 2009 by Dekker called Hi-C to generate a three-dimensional model of a pro-B cell (white blood cell) from a mouse. At the same time, a high-throughput genome-wide translocation sequencing (HTGTS) technique developed by Dr. Alt's lab was used to map "hot spots" in the genome where chromosome breaks and translocations are more likely to occur. By combining the 3D model of the genome, the first for a mouse, with the sites of translocations in these cells, researchers were able to explore the role spatial proximity plays in the reassembly of these chromosome breaks.
What they observed is that for random, widespread, low-frequency DNA breaks, such as might occur after exposure to too much sun or chemotherapy, spatial proximity plays a dominant role in determining where in the genome these pieces of chromosome get reattached. Simply stated, the closer the breaks were to each other, the more likely they were to be incorrectly attached to a neighboring chromosome. Dekker and colleagues also observed that chromosome breaks were also more likely to be translocated along the whole chromosome where they resided, adding further evidence that spatial organization is a determining factor in chromosome translocations.
"We see the same chromosome rearrangements happening over and over again in certain cancers, but determining the role of spatial proximity in this process has been a hard question to answer," said Dekker, also professor of biochemistry & molecular pharmacology and molecular medicine at UMMS. "By generating a 3D model of the entire genome and mapping translocations from targeted chromosome breaks we can finally start to answer this question."
###
About the University of Massachusetts Medical School The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $277 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. For more information, visit www.umassmed.edu.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 16-Feb-2012[ | E-mail |
Share ] Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
UMass Medical School study offers evidence that the 3D organization of chromosomes plays a part in cancer genomics
WORCESTER, Mass. -- It is well understood that chromosomal translocation a process whereby pieces of two chromosomes break off and exchange places is a hallmark of many cancers including leukemia, thyroid cancer and lymphoma and play an important part in how healthy cells become cancerous. The role spatial proximity plays in why certain chromosomal translocations happen repeatedly, however, has been a long-standing area of debate among scientists.
A new study published online in the journal Cell by lead authors Job Dekker, PhD, co-director of the Program in Systems Biology at the University of Massachusetts Medical School (UMMS) and Frederick Alt, PhD, director of the Program in Cellular and Molecular Medicine at Children's Hospital Boston, offers the first conclusive evidence that the three dimensional structure of the chromosome strongly influences patterns of chromosome rearrangements and translocations. This finding sheds light on fundamental processes related to cancer and our understanding of cancer genomics.
"Understanding how chromosome translocations happen is important if we want to understand the evolution of cancer genomes," said Rachel Patton McCord, PhD, a postdoctoral fellow at UMMS and co-first author of the study. "If certain individuals have changes in their chromosome structure it might indicate an increased risk for translocations that give rise to cancer. And, after precancerous changes have taken place in the genome of the cell, corresponding rearrangements in the 3D genome may dictate which translocations happen as cancer progresses."
In order to measure how all the sequences in the genome are organized relative to one another, McCord used a molecular technology developed in 2009 by Dekker called Hi-C to generate a three-dimensional model of a pro-B cell (white blood cell) from a mouse. At the same time, a high-throughput genome-wide translocation sequencing (HTGTS) technique developed by Dr. Alt's lab was used to map "hot spots" in the genome where chromosome breaks and translocations are more likely to occur. By combining the 3D model of the genome, the first for a mouse, with the sites of translocations in these cells, researchers were able to explore the role spatial proximity plays in the reassembly of these chromosome breaks.
What they observed is that for random, widespread, low-frequency DNA breaks, such as might occur after exposure to too much sun or chemotherapy, spatial proximity plays a dominant role in determining where in the genome these pieces of chromosome get reattached. Simply stated, the closer the breaks were to each other, the more likely they were to be incorrectly attached to a neighboring chromosome. Dekker and colleagues also observed that chromosome breaks were also more likely to be translocated along the whole chromosome where they resided, adding further evidence that spatial organization is a determining factor in chromosome translocations.
"We see the same chromosome rearrangements happening over and over again in certain cancers, but determining the role of spatial proximity in this process has been a hard question to answer," said Dekker, also professor of biochemistry & molecular pharmacology and molecular medicine at UMMS. "By generating a 3D model of the entire genome and mapping translocations from targeted chromosome breaks we can finally start to answer this question."
###
About the University of Massachusetts Medical School The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $277 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. For more information, visit www.umassmed.edu.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2012-02/uomm-spp021612.php
dark knight rises trailer latkes how to make it in america how to make it in america schweddy balls schweddy balls hedy lamarr
No comments:
Post a Comment